Filing Details

Accession Number:
0001209191-14-062972
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-10-10 22:46:20
Reporting Period:
2014-10-08
Filing Date:
2014-10-10
Accepted Time:
2014-10-10 21:46:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
876343 Biotime Inc BTX Biological Products, (No Disgnostic Substances) (2836) 943127919
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1188757 C Stephen Farrell 13621 Nw 12 Street,
Suite 100
Sunrise FL 33323
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares, No Par Vaule Acquisiton 2014-10-08 32,050 $3.12 47,450 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Shares Option to Purchase Common Shares $3.11 2019-06-30 20,000 20,000 Direct
Common Shares Option to Purchase Common Shares $4.13 2018-06-30 20,000 20,000 Direct
Common Shares Option to Purchase Common Shares $4.12 2018-03-10 20,000 20,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2019-06-30 20,000 20,000 Direct
2018-06-30 20,000 20,000 Direct
2018-03-10 20,000 20,000 Direct
Footnotes
  1. Shares acquired pursuant to a Stock Purchase Agreement dated October 3, 2014.
  2. Will become exercisable in four equal quarterly installments after the date of grant on July 1, 2014 based upon continued service on the board of directors.
  3. Became exercisable in four equal quarterly installments after the date of grant on July 1, 2013 based upon continued service on the board of directors.
  4. Became exercisable in four equal quarterly installments after the date of grant on May 11, 2013 based upon continued service on the board of directors.